APA (7th ed.) Citation

Y, L., Y, Z., J, H., HT, K., Q, S., RP, B., . . . PH, B. (2008). The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice. British journal of cancer, 98(8), 1380. https://doi.org/10.1038/sj.bjc.6604320

Chicago Style (17th ed.) Citation

Y, Li, Zhang Y, Hill J, Kim HT, Shen Q, Bissonnette RP, Lamph WW, and Brown PH. "The Rexinoid, Bexarotene, Prevents the Development of Premalignant Lesions in MMTV-erbB2 Mice." British Journal of Cancer 98, no. 8 (2008): 1380. https://doi.org/10.1038/sj.bjc.6604320.

MLA (9th ed.) Citation

Y, Li, et al. "The Rexinoid, Bexarotene, Prevents the Development of Premalignant Lesions in MMTV-erbB2 Mice." British Journal of Cancer, vol. 98, no. 8, 2008, p. 1380, https://doi.org/10.1038/sj.bjc.6604320.